| pubmed-article:9746382 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9746382 | lifeskim:mentions | umls-concept:C0032961 | lld:lifeskim |
| pubmed-article:9746382 | lifeskim:mentions | umls-concept:C0043210 | lld:lifeskim |
| pubmed-article:9746382 | lifeskim:mentions | umls-concept:C0013227 | lld:lifeskim |
| pubmed-article:9746382 | lifeskim:mentions | umls-concept:C0086343 | lld:lifeskim |
| pubmed-article:9746382 | lifeskim:mentions | umls-concept:C0332157 | lld:lifeskim |
| pubmed-article:9746382 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:9746382 | lifeskim:mentions | umls-concept:C0014282 | lld:lifeskim |
| pubmed-article:9746382 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:9746382 | pubmed:dateCreated | 1998-10-26 | lld:pubmed |
| pubmed-article:9746382 | pubmed:abstractText | To determine the proportion and nature of congenital anomalies in babies born to women exposed to newly marketed drugs during the first trimester. | lld:pubmed |
| pubmed-article:9746382 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9746382 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9746382 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9746382 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9746382 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9746382 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9746382 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9746382 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9746382 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:9746382 | pubmed:issn | 0306-5456 | lld:pubmed |
| pubmed-article:9746382 | pubmed:author | pubmed-author:MannR DRD | lld:pubmed |
| pubmed-article:9746382 | pubmed:author | pubmed-author:MartinR MRM | lld:pubmed |
| pubmed-article:9746382 | pubmed:author | pubmed-author:WiltonL VLV | lld:pubmed |
| pubmed-article:9746382 | pubmed:author | pubmed-author:PearceG LGL | lld:pubmed |
| pubmed-article:9746382 | pubmed:author | pubmed-author:MackayF JFJ | lld:pubmed |
| pubmed-article:9746382 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9746382 | pubmed:volume | 105 | lld:pubmed |
| pubmed-article:9746382 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9746382 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9746382 | pubmed:pagination | 882-9 | lld:pubmed |
| pubmed-article:9746382 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:9746382 | pubmed:meshHeading | pubmed-meshheading:9746382-... | lld:pubmed |
| pubmed-article:9746382 | pubmed:meshHeading | pubmed-meshheading:9746382-... | lld:pubmed |
| pubmed-article:9746382 | pubmed:meshHeading | pubmed-meshheading:9746382-... | lld:pubmed |
| pubmed-article:9746382 | pubmed:meshHeading | pubmed-meshheading:9746382-... | lld:pubmed |
| pubmed-article:9746382 | pubmed:meshHeading | pubmed-meshheading:9746382-... | lld:pubmed |
| pubmed-article:9746382 | pubmed:meshHeading | pubmed-meshheading:9746382-... | lld:pubmed |
| pubmed-article:9746382 | pubmed:meshHeading | pubmed-meshheading:9746382-... | lld:pubmed |
| pubmed-article:9746382 | pubmed:meshHeading | pubmed-meshheading:9746382-... | lld:pubmed |
| pubmed-article:9746382 | pubmed:meshHeading | pubmed-meshheading:9746382-... | lld:pubmed |
| pubmed-article:9746382 | pubmed:meshHeading | pubmed-meshheading:9746382-... | lld:pubmed |
| pubmed-article:9746382 | pubmed:meshHeading | pubmed-meshheading:9746382-... | lld:pubmed |
| pubmed-article:9746382 | pubmed:meshHeading | pubmed-meshheading:9746382-... | lld:pubmed |
| pubmed-article:9746382 | pubmed:meshHeading | pubmed-meshheading:9746382-... | lld:pubmed |
| pubmed-article:9746382 | pubmed:meshHeading | pubmed-meshheading:9746382-... | lld:pubmed |
| pubmed-article:9746382 | pubmed:meshHeading | pubmed-meshheading:9746382-... | lld:pubmed |
| pubmed-article:9746382 | pubmed:meshHeading | pubmed-meshheading:9746382-... | lld:pubmed |
| pubmed-article:9746382 | pubmed:meshHeading | pubmed-meshheading:9746382-... | lld:pubmed |
| pubmed-article:9746382 | pubmed:meshHeading | pubmed-meshheading:9746382-... | lld:pubmed |
| pubmed-article:9746382 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9746382 | pubmed:articleTitle | The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. | lld:pubmed |
| pubmed-article:9746382 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9746382 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9746382 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9746382 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9746382 | lld:pubmed |
